Table 1.
Characteristics of the patients infected by HEV-3 strain with genomic rearrangements.
| HEV strain | Pathology of the patient | HEV diagnosis | Chronic/acute HEV infection at the time of diagnosis | Plasma HEV RNA concentration (log copies/ml) | Time between HEV infection and detection of genomic rearrangement |
|---|---|---|---|---|---|
| 6 | Chronic lymphoid leukemia | 2014 | Acute | 7.5 | <2 months |
| 26 | Renal transplant | 2013 | Acute | 5.8 | <2 months |
| 94 | Hepatic transplant | 2013 | Acute | 6.6 | <2 months |
| 93 | Hepatic transplant | 2013 | Chronic | 7.5 | 3 months |
| 154 | Chronic lymphoid leukemia | 2014 | Chronic | 5.3 | 5 months |
| 64 | Cardiac transplant | 2009 | Chronic | 6.2 | 9 months |
| 12 | Light chain myeloma | 2010 | Chronic | 7.7 | 10 months |